Non-clinical investigation of the dependence potential of medicinal products

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCHMP/SWP/94227/04
Effective from01/09/2006
KeywordsDependence potential, non-clinical, behavioural studies, opioids, central nervous system (CNS) stimulants, sedatives, anxiolytics
DescriptionThis document describes the need for testing of dependence potential in animals during the development of pharmaceuticals. It indicates what type of information is expected to support the assessment of human safety with respect to dependence potential of a medicinal product.

Related content

How helpful is this page?

Average rating:

 Based on 26 ratings

Add your rating:

See all ratings
5 ratings
5 ratings
5 ratings
5 ratings
6 ratings

Tell us more